Health technology prioritization: Which criteria for prioritizing new technologies and what are their relative weights?

Health technology prioritization: Which criteria for prioritizing new technologies and what are their relative weights?
复制标题

DOI:
10.1016/j.healthpol.2010.10.012
复制
发表时间:
2011-10-01
期刊:
影响因子:
3.3
通讯作者:
Tal, Orna
Tal, Orna
中科院分区:
医学3区
文献类型:
--
作者:
Golan, Ofra;Hansen, Paul;Tal, Orna

文献摘要

被引文献

相似文献

目的:要审查的标准和“其他”的考虑因素,国际上优先考虑新的卫生技术,并证明一个联合分析方法(也称为离散选择实验)推导出相对权重的criterion.Methods:我们搜索文献的标准和其他考虑因素,优先考虑新技术。一个方便的样本74名受访者完成了一项联合分析调查,涉及标准相关的技术'benefits. Results:包括11个国家和美国的俄勒冈州,我们能够区分三个主要组的标准:(a)需要,适当性和临床效益;(B)效率(包括成本效益);和(c)平等,团结和其他道德或社会价值。对于一些国家,还考虑了临床和经济证据的质量以及分别与战略问题和程序公正相关的因素。联合分析调查的标准及其权重为:“挽救的生命”= 0.343,“延长寿命的益处”= 0.243,“生活质量的提高”= 0.217,代表替代治疗的可用性的标准= 0.107,以及“其他重要的社会/伦理益处”= 0.087。这些标准代表了基于需求、最大化和平等主义原则的多元组合,我们展示了一种方法,用于推导与技术"效益“相关的标准权重。(C)2010爱思唯尔爱尔兰有限公司版权所有。
Objectives: To review the criteria and 'other' considerations used internationally for prioritizing new health technologies, and to demonstrate a conjoint-analysis methodology (also known as discrete choice experiments) for deriving relative weights for the criteria.Methods: We searched the literature for criteria and other considerations for prioritizing new technologies. A convenience sample of 74 respondents completed a conjoint-analysis survey involving criteria related to technologies' 'benefits'.Results: Encompassing 11 countries and the US state of Oregon, we were able to distinguish three main groups of criteria: (a) Need, appropriateness and clinical benefits; (b) Efficiency (including cost-effectiveness); and (c) Equality, solidarity and other ethical or social values. For several countries, the quality of the clinical and economic evidence and factors related to strategic issues and procedural justice respectively are also considered. The criteria and their weights from the conjoint-analysis survey are: 'Lives saved' = 0.343, life-prolongation benefits' 0.243, 'Quality-of-life gains' = 0.217, a criterion representing the availability of alternative treatments = 0.107, and 'Other important social/ethical benefits' = 0.087.Conclusions: The criteria represent a pluralistic combination of needs-based, maximizing and egalitarian principles, and we demonstrated a methodology for deriving the weights for criteria related to technologies' 'benefits'. (C) 2010 Elsevier Ireland Ltd. All rights reserved.